ABPI response to new genomics funding

29 April 2021 Posted in News by Press Office

Speaking at the ABPI annual conference, health secretary Matt Hancock announced £37 million for genomics projects and data-driven initiatives delivered through the Genome UK Implementation Plan and the UK Functional Genomics Initiative.

Genomics and data will be at the heart of the next generation of personalised healthcare and today’s announcement will help put the UK at the cutting edge of medicines and vaccines development. Richard Torbett

In response, Richard Torbett, Chief Executive of the ABPI, said:

“The past year has shown us all the importance of having a strong domestic life sciences sector that is able to respond quickly to health challenges and support the NHS in times of crisis.

"Today’s announcement recognises the part our companies have played in the battle against COVID-19 and sends a clear signal about industry’s role in the government’s plan for the UK as a science superpower.”

"Genomics and data will be at the heart of the next generation of personalised healthcare and today’s announcement will help put the UK at the cutting edge of medicines and vaccines development.”

TAGS
  • Genomics

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

Media enquiries

+44 (0) 20 7747 7147​​